Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives
about
Other targeted drugs in melanomaThe rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCCExploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches.Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors.Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.Rational design, synthesis, and biological evaluation of Pan-Raf inhibitors to overcome resistance.An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling.Computational study on the unbinding pathways of B-RAF inhibitors and its implication for the difference of residence time: insight from random acceleration and steered molecular dynamics simulations.BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.New perspectives for targeting RAF kinase in human cancer.Energetics and structural characterization of the "DFG-flip" conformational transition of B-RAF kinase: a SITS molecular dynamics study.A modified gene trap approach for improved high-throughput cancer drug discovery.Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer
P2860
Q26775594-64E739EF-A2AF-4FDB-A138-427EF50248B0Q28540228-621994F1-0D5D-4094-9F29-AAAB521735A9Q30395364-628A4547-D64A-44B4-8094-EB0B4E0CA85AQ36247419-18E81718-A459-427E-8F76-AC4F3C9916CFQ36359700-0B4CBD84-B3BE-45E0-9992-2543A6974B62Q37706929-6D0000EA-F655-45AD-A0F3-C08A391711D2Q38709303-53EB8C13-B9B1-40E5-8572-16BA86A2719DQ38752000-3E79817A-80F3-48B6-A4A8-4CA99504104FQ38910052-774E58EB-0914-4E55-BEC5-441AAD68FF69Q39381021-2BA06871-7CB4-4E0B-9F94-D3B090F2107EQ47688064-FF6139CC-5E0E-4DF0-88E1-8A175BDA36D8Q48052175-8F124BCB-4CE8-4F2F-B023-5C834C6471A0Q52714926-D2681091-E735-4CC8-8F8F-075B5544B625Q58806326-DD71BD69-384F-4C2D-8407-FD229ECBDA5F
P2860
Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@ast
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@en
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@nl
type
label
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@ast
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@en
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@nl
prefLabel
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@ast
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@en
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@nl
P2093
P356
P1476
Discovery of a selective kinas ...... 1,3-benzothiazole derivatives
@en
P2093
Akihiko Sumita
Akito Nakamura
Bi-Ching Sang
Jason Yano
Kathleen Aertgeerts
Masaaki Hirose
Masanori Okaniwa
Masato Yabuki
Noriko Uchiyama
Sei Yoshida
P304
P356
10.1021/JM400778D
P407
P577
2013-08-22T00:00:00Z